Archive for November 24th, 2009

Lethal Lag Time: Concerns, Possible Solutions

November 24, 2009

In a follow up from yesterday’s post, I came across an article in the Journal of the National Cancer Institute on a drug funding issue force one of the major cooperative oncology groups to modify how they approach clinical trials. The article, titled,
Costly Cancer Drugs Trigger Proposals To Modify Clinical Trial Design” notes a new drug costing up to $9000 per month per patient. In doing the economic analysis using formulas like Quality Adjust Life Years (QALYs), the real value of these treatments is being questioned.
On the brighter side, two potential solutions to long lag times for research are a search tool and a predictive modeling tool.

  • explorys is a new spin off from the Cleveland Clinic which “enables users to collaborate, search, and tag meaningful correlations from treatments and outcomes within patient populations while maintaining security and privacy.” Hoping to get a demo soon.
  • Archimedes Model which is reviewed recently in Business Week
    and in Wired Magazine this month. which is a predictive modeling tool which is a full-scale simulation model of human physiology, diseases, behaviors, interventions, and healthcare systems.
Share this:
  • Facebook
  • Twitter
  • Delicious
  • Digg
  • Tumblr
  • StumbleUpon
  • Pinterest
  • Add to favorites
  • Email
  • RSS

Lethal Lag Time: Defining and Advocating

November 24, 2009

Lethal Lag Time is described in the in the e-Patient While Paper (page 87) in the context of bypassing the lag time by using patient-initiated research. But are there other ways to accelerate traditional clinical trials or provide other alternatives to answer research questions. A search of the term “clinical trial failures” yields only 7 results on Pubmed. Clinical trial recruitment yields on 29 results. Don’t we need more study of research to understand some of the problems in clinical trials, such as, failures and recruitment problems? Are there ways to examine each phase – protocol development, funding, recruitment, even publication etc.? The Obama administration is providing some DOD grants which are simple application processes and rapid decision cycles.  Why can’t a similar program be applied to medical research grants?
Finally, is there a way to inject the urgency of a term like Lethal Lag Time into the medical research discussion including the professional literature? Not sure how we can do this but Participatory Medicine and e-Patient involvement are key. Watch for more blog posts on this topic.

Share this:
  • Facebook
  • Twitter
  • Delicious
  • Digg
  • Tumblr
  • StumbleUpon
  • Pinterest
  • Add to favorites
  • Email
  • RSS